During these tough times, we continue to advocate for lung cancer patients and caregivers. This section is dedicated to policy endeavors related specifically to COVID-19 that LUNGevity is involved in. We have a separate public policy section where you can learn more about LUNGevity's other advocacy work in support of the lung cancer community.
Collaborative policy letters
LUNGevity works collaboratively with many other health-related organizations in submitting letters to federal lawmakers and regulatory agencies. This kind of input is critical in developing policies that improve patients' access to care and advancing innovation that will benefit people with lung cancer.
Here are some COVID-19-specific letters that LUNGevity has signed:
- Sign-on letter to Office of Civil Rights on emergency triage plans (May 20, 2020)
- Cancer community anti-discrimination sign-on letter to governors (April 21, 2020)
- Cancer community sign-on letter to Hill leadership regarding important policy changes for cancer patients during COVID crisis (April 15, 2020)
- Cancer community sign-on letter to HHS regarding important policy changes for cancer patients during COVID crisis (April 15, 2020)
- Joint Statement on COVID-19 Triage of Lung Cancer Patients (April 7, 2020)
- HHS's Guidance on Avoiding Disability-Based Discrimination in Treatment Rationing (April 3, 2020)
- Letter to Congress: Medications Access Must Be Included in Third COVID-19 Package (March 26, 2020)
- Letter to President Trump: Domestic manufacture of health care products (March 25, 2020)
- Letter to Congress: Potential Aid for Patient Organizations Impacted by Coronavirus (March 26, 2020)
- The Charitable Sector: COVID-19 Relief and Economic Stimulus Package (March 23, 2020)
- Letter to states to protect access to medications for high-risk populations during COVID-19 (March 20, 2020)
